Avi Gnatt

Affiliated with

Research Area

Biography

Avi Gnatt has not added Biography.
If you are Avi Gnatt and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 12	2013

Other Publications

Article	Year
Intramolecular relationships in cholinesterases revealed by oocyte expression of site-directed and natural variants of human BCHE. The EMBO journal\| PubMed ID: 1373381	1992
Excavations into the active-site gorge of cholinesterases. Trends in biochemical sciences\| PubMed ID: 1412713	1992
Human acetylcholinesterase and butyrylcholinesterase are encoded by two distinct genes. Cellular and molecular neurobiology\| PubMed ID: 2013062	1991
Aspartate-70 to glycine substitution confers resistance to naturally occurring and synthetic anionic-site ligands on in-ovo produced human butyrylcholinesterase. Journal of neuroscience research\| PubMed ID: 2079709	1990
Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations. The Journal of biological chemistry\| PubMed ID: 2249982	1990
Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 2263619	1990
Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors. Cancer research\| PubMed ID: 2317787	1990
Molecular cloning of human cholinesterase genes: potential applications in neurotoxicology. Progress in clinical and biological research\| PubMed ID: 2963345	1987
Isolation and characterization of full-length cDNA clones coding for cholinesterase from fetal human tissues. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 3035536	1987
Molecular biological search for human genes encoding cholinesterases. Molecular neurobiology\| PubMed ID: 3077058	1987
Use of synthetic oligodeoxynucleotide probes for the isolation of a human cholinesterase cDNA clone. Journal of neuroscience research\| PubMed ID: 3755763	1986
Testicular amplification and impaired transmission of human butyrylcholinesterase cDNA in transgenic mice. Human reproduction (Oxford, England)\| PubMed ID: 8027285	1994
Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands. Journal of molecular biology\| PubMed ID: 8230213	1993
Structure-function relationship studies in human cholinesterases reveal genomic origins for individual variations in cholinergic drug responses. Progress in neuro-psychopharmacology & biological psychiatry\| PubMed ID: 8278601	1993
Site-directed mutagenesis of active site residues reveals plasticity of human butyrylcholinesterase in substrate and inhibitor interactions. Journal of neurochemistry\| PubMed ID: 8294937	1994
Evidence for a mediator cycle at the initiation of transcription. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 9177171	1997
Formation and crystallization of yeast RNA polymerase II elongation complexes. The Journal of biological chemistry\| PubMed ID: 9388221	1997
Repeated tertiary fold of RNA polymerase II and implications for DNA binding. Journal of molecular biology\| PubMed ID: 9665838	1998
Electron crystal structure of an RNA polymerase II transcription elongation complex. Cell\| PubMed ID: 10499796	1999
Yeast RNA polymerase II at 5 A resolution. Cell\| PubMed ID: 10499797	1999
Architecture of RNA polymerase II and implications for the transcription mechanism. Science (New York, N.Y.)\| PubMed ID: 10784442	2000
Structural basis of transcription: an RNA polymerase II elongation complex at 3.3 A resolution. Science (New York, N.Y.)\| PubMed ID: 11313499	2001
Elongation by RNA polymerase II: structure-function relationship. Biochimica et biophysica acta\| PubMed ID: 12213651	2002
Cancer outcomes at the Hufeland (complementary/alternative medicine) klinik: a best-case series review. Integrative cancer therapies\| PubMed ID: 15911928	2005
Fcp1 directly recognizes the C-terminal domain (CTD) and interacts with a site on RNA polymerase II distinct from the CTD. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 16301539	2005
A Mediator-responsive form of metazoan RNA polymerase II. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 16769904	2006
Knockdown of TFIIS by RNA silencing inhibits cancer cell proliferation and induces apoptosis. BMC cancer\| PubMed ID: 18474089	2008
Differential blocking effects of the acetaldehyde-derived DNA lesion N2-ethyl-2'-deoxyguanosine on transcription by multisubunit and single subunit RNA polymerases. The Journal of biological chemistry\| PubMed ID: 18669632	2008
Regulation of RUNX2 transcription factor-DNA interactions and cell proliferation by vitamin D3 (cholecalciferol) prohormone activity. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research\| PubMed ID: 22189971	2012
Functional association of Gdown1 with RNA polymerase II poised on human genes. Molecular cell\| PubMed ID: 22244331	2012
Transcriptional regulation by Pol II(G) involving mediator and competitive interactions of Gdown1 and TFIIF with Pol II. Molecular cell\| PubMed ID: 22244332	2012
Efficient reconstitution of transcription elongation complexes for single-molecule studies of eukaryotic RNA polymerase II. Transcription\| PubMed ID: 22771949	2012
Regulation of mammalian transcription by Gdown1 through a novel steric crosstalk revealed by cryo-EM. The EMBO journal\| PubMed ID: 22850672	2012
Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides. PLoS pathogens\| PubMed ID: 23166498	2012